VBI Vaccines (VBIV) –
-
Form SC 13D/A VBI Vaccines Inc/BC Filed by: PERCEPTIVE ADVISORS LLC
-
Form 10-K VBI Vaccines Inc/BC For: Dec 31
-
Form 8-K VBI Vaccines Inc/BC For: Apr 16
-
VBI Vaccines Reports Full Year 2023 Financial Results
-
Form 8-K VBI Vaccines Inc/BC For: Apr 09
-
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
Form 424B5 VBI Vaccines Inc/BC
-
VBI Vaccines (VBIV) Announces $2 Million Registered Direct Offering Priced At-the-Market
-
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
-
VBI Vaccines (VBIV) Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
-
Form 8-K VBI Vaccines Inc/BC For: Apr 03
-
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma
-
VBI Vaccines (VBIV) Expands Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
-
Form 8-K VBI Vaccines Inc/BC For: Apr 02
-
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform
-
Form NT 10-K VBI Vaccines Inc/BC For: Dec 31
-
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results
-
Form 8-K VBI Vaccines Inc/BC For: Feb 14
-
VBI Vaccines (VBIV) to Sell Manufacturing Capabilities, Certain Related Assets, Enters New License Agreement with Brii Biosciences
-
VBI Announces Agreement to Sell Manufacturing Capabilities, Certain Related Assets, and Enter Into New License Agreement with Brii Biosciences
-
VBI Vaccines (VBI) to Sell IP Rights for VBI-2601 to Brii Biosciences
-
Brii Biosciences Announces Agreement to Acquire VBI's IP Rights in BRII-179 (VBI-2601) and Plans to Initiate Technology Transfer to Expand Clinical and Commercial Supplies
-
Form 8-K VBI Vaccines Inc/BC For: Feb 06
-
Form 8-K VBI Vaccines Inc/BC For: Jan 23
-
Form 8-K VBI Vaccines Inc/BC For: Jan 09
-
Form 8-K VBI Vaccines Inc/BC For: Dec 26
-
Form 8-K VBI Vaccines Inc/BC For: Dec 12
-
Form 8-K VBI Vaccines Inc/BC For: Nov 28
-
VBI Vaccines (VBIV) Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901
-
Form 8-K VBI Vaccines Inc/BC For: Nov 20
-
VBI Vaccines Presents Additional Biomarker Data from Phase 1/2a Study of VBI-1901 in Recurrent GBM at the 2023 Society for Neuro-Oncology (SNO) Annual Meeting
-
Form SC 13D/A VBI Vaccines Inc/BC Filed by: PERCEPTIVE ADVISORS LLC
-
VBI Vaccines (VBIV) Misses Q3 EPS by 38c
-
Form 10-Q VBI Vaccines Inc/BC For: Sep 30
-
Form 8-K VBI Vaccines Inc/BC For: Nov 14
-
VBI Vaccines Reports Third Quarter 2023 Financial Results
-
Form 8-K VBI Vaccines Inc/BC For: Nov 01
-
VBI Vaccines (VBIV) Announces Development of a Novel mRNA-Launched eVLP Vaccine Program
-
Form 8-K VBI Vaccines Inc/BC For: Oct 26
-
VBI Vaccines Expands Proprietary Technology Platforms With Development of a Novel mRNA-Launched eVLP Vaccine Program
-
VBI Vaccines (VBIV) Reports VBI-2901 Induced Broad and Durable Protective Titers Against Variants of Concern
-
Form 8-K VBI Vaccines Inc/BC For: Sep 27
-
VBI Vaccines’ Pan-Coronavirus Vaccine Candidate, VBI-2901, Induced Broad and Durable Protective Titers Against Variants of Concern
-
Form 8-K VBI Vaccines Inc/BC For: Sep 07
-
VBI Vaccines Announces Dosing of First Patients in Phase 2b Study of VBI-1901 in Recurrent GBM
-
Form 8-K VBI Vaccines Inc/BC For: Sep 06
-
VBI Vaccines (VBIV) Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study of BRII-179
-
VBI Vaccines Partner Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination With PEG-IFNα for the Treatment of Chronic Hepatitis B
-
Brii Biosciences Announces Topline Interim Results of Phase 2 Study Evaluating BRII-179 (VBI-2601) in Combination with PEG-IFNα for the Treatment of Chronic Hepatitis B
-
Brii Biosciences Provides Corporate Updates and Reports 2023 Interim Results
Back to VBIV Stock Lookup
